Dopamine Precursor Depletion Influences Pain Affect Rather than Pain Sensation

Pain is a multidimensional experience, which includes sensory, cognitive, and affective aspects. Converging lines of evidence indicate that dopaminergic neurotransmission plays an important role in human pain perception. However, the precise effects of dopamine on different aspects of pain perception remain to be elucidated. To address this question, we experimentally decreased dopaminergic neurotransmission in 22 healthy human subjects using Acute Phenylalanine and Tyrosine Depletion (APTD). During APTD and a control condition we applied brief painful laser stimuli to the hand, assessed different aspects of pain perception, and recorded electroencephalographic responses. APTD-induced decreases of cerebral dopaminergic activity did not influence sensory aspects of pain perception. In contrast, APTD yielded increases of pain unpleasantness. The increases of unpleasantness ratings positively correlated with effectiveness of APTD. Our finding of an influence of dopaminergic neurotransmission on affective but not sensory aspects of phasic pain suggests that analgesic effects of dopamine might be mediated by indirect effects on pain affect rather than by direct effects on ascending nociceptive signals. These findings contribute to our understanding of the complex relationship between dopamine and pain perception, which may play a role in various clinical pain states.

[1]  C. Benkelfat,et al.  Effects on Mood of Acute Phenylalanine/Tyrosine Depletion in Healthy Women , 2000, Neuropsychopharmacology.

[2]  I. Eli,et al.  Pain perception in patients with schizophrenia. , 2002, The Journal of nervous and mental disease.

[3]  Manpreet K. Singh,et al.  Pain Insensitivity in Schizophrenia: Trait or State Marker? , 2006, Journal of psychiatric practice.

[4]  P. Schweinhardt,et al.  Dopamine and Pain Sensitivity: Neither Sulpiride nor Acute Phenylalanine and Tyrosine Depletion Have Effects on Thermal Pain Sensations in Healthy Volunteers , 2013, PloS one.

[5]  R. Ebstein,et al.  Dopamine Transporter Genotype Dependent Effects of Apomorphine on Cold Pain Tolerance in Healthy Volunteers , 2013, PloS one.

[6]  John J Sunderland,et al.  Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. , 2007, The journal of pain : official journal of the American Pain Society.

[7]  W. Schultz Multiple dopamine functions at different time courses. , 2007, Annual review of neuroscience.

[8]  I. Stolerman Encyclopedia of Psychopharmacology , 2015, Springer Berlin Heidelberg.

[9]  Massimiliano Valeriani,et al.  Abnormal processing of the nociceptive input in Parkinson’s disease: A study with CO2 laser evoked potentials , 2008, PAIN.

[10]  J. Stamford Descending control of pain. , 1995, British journal of anaesthesia.

[11]  Marcel Heiman,et al.  Textbook of Psychiatry , 1940, Mental Health.

[12]  A. Nieoullon Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.

[13]  F. Chollet,et al.  Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[14]  Kjell Någren,et al.  Striatal dopamine D1 and D2 receptors in burning mouth syndrome , 2003, Pain.

[15]  G. Deuschl,et al.  Pains in Parkinson disease—many syndromes under one umbrella , 2012, Nature Reviews Neurology.

[16]  A. López‐Avila,et al.  Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex , 2004, Pain.

[17]  R. Koeppe,et al.  Variations in the Human Pain Stress Experience Mediated by Ventral and Dorsal Basal Ganglia Dopamine Activity , 2006, The Journal of Neuroscience.

[18]  A. Holman,et al.  A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. , 2005, Arthritis and rheumatism.

[19]  D. Yarnitsky,et al.  Quantitative measurement of pain sensation in patients with Parkinson disease , 2004, Neurology.

[20]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .

[21]  L. Garcia-Larrea,et al.  Contribution of attentional and cognitive factors to laser evoked brain potentials , 2003, Neurophysiologie Clinique/Clinical Neurophysiology.

[22]  Robert A. Koeppe,et al.  Individual Differences in Reward Responding Explain Placebo-Induced Expectations and Effects , 2007, Neuron.

[23]  F. López-Muñoz,et al.  Dopamine receptors in the anterior insular cortex modulate long‐term nociception in the rat , 2008, European journal of pain.

[24]  E. London,et al.  Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction , 2012, PAIN®.

[25]  M. Frot,et al.  Brain generators of laser-evoked potentials: from dipoles to functional significance , 2003, Neurophysiologie Clinique/Clinical Neurophysiology.

[26]  J. Salamone,et al.  The Mysterious Motivational Functions of Mesolimbic Dopamine , 2012, Neuron.

[27]  Serge Marchand,et al.  Human evidence of a supra‐spinal modulating role of dopamine on pain perception , 2009, Synapse.

[28]  Chourouk Mzahi Reshaping the Village Test for investigating service brand attachment , 2014 .

[29]  S. Kernbaum,et al.  Administration of levodopa for relief of herpes zoster pain. , 1981, JAMA.

[30]  K. Någren,et al.  Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity , 2002, PAIN.

[31]  J. Stewart,et al.  The role of dopamine in the nucleus accumbens in analgesia. , 1999, Life sciences.

[32]  M. Ploner,et al.  Behavioral and Neuronal Investigations of Hypervigilance in Patients with Fibromyalgia Syndrome , 2012, PloS one.

[33]  B. Uludaǧ,et al.  Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy , 1998, Pain.

[34]  Stefano Tamburin,et al.  Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser‐evoked potentials , 2010, Movement disorders : official journal of the Movement Disorder Society.

[35]  E. Tolosa,et al.  Neurophysiologic study of central pain in patients with Parkinson disease , 2007, Neurology.

[36]  M. Bushnell,et al.  Response to heat pain stimulation in idiopathic Parkinson's disease. , 2010, Pain medicine.

[37]  Joachim Gross,et al.  Neurophysiological coding of traits and states in the perception of pain. , 2011, Cerebral cortex.

[38]  J. Rinne,et al.  Role of the dopaminergic system in chronic pain – a fluorodopa-PET study , 2001, Pain.

[39]  Kjell Någren,et al.  Altered dopamine D2 receptor binding in atypical facial pain , 2003, Pain.

[40]  I. Tracey,et al.  A common neurobiology for pain and pleasure , 2008, Nature Reviews Neuroscience.

[41]  A. Badawy Acute tryptophan or tyrosine depletion test: time for reappraisal? , 2005, Journal of psychopharmacology.

[42]  Joachim Gross,et al.  Gamma oscillations as a neuronal correlate of the attentional effects of pain , 2010, PAIN.

[43]  B. Ford Pain in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[44]  Susanne Becker,et al.  Cerebral interactions of pain and reward and their relevance for chronic pain , 2012, Neuroscience Letters.

[45]  Alain Dagher,et al.  Fibromyalgia patients show an abnormal dopamine response to pain , 2007, The European journal of neuroscience.

[46]  G. Koob Hedonic valence, dopamine and motivation. , 1996, Molecular psychiatry.

[47]  R. Treister,et al.  The dopamine agonist apomorphine enhances conditioned pain modulation in healthy humans , 2013, Neuroscience Letters.

[48]  P. Wood Role of central dopamine in pain and analgesia , 2008, Expert review of neurotherapeutics.

[49]  K. Någren,et al.  Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia , 2005, Neuroscience Letters.

[50]  F. Ory-Magne,et al.  Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[51]  Robert Oostenveld,et al.  Localizing human visual gamma-band activity in frequency, time and space , 2006, NeuroImage.

[52]  K. Någren,et al.  Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain , 2004, The European journal of neuroscience.

[53]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.